Drug discontinuation: Felodipine Tablet, Extended Release
FDA lists 4 presentations as To Be Discontinued. Companies: Par Health, USA LLC.
- Published by source
- 2026-10-07
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Par Health, USA LLC
- Products
- Felodipine Tablet, Extended Release
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation in the manufacturing of the drug product
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-10-07
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #943 | new | 2026-10-22 | 196ab3c15efc…37c7d4 | 77d67bf8a07f…b10d14 |
Chain head: #1076 8ad5adc30b9b…88ce20